LifeStance Health Group, Inc.

NASDAQ•LFST

CEO: Mr. Kenneth Alan Burdick

セクター: Healthcare

業種: Medical - Care Facilities

上場日: 2021-06-10

LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.

連絡先情報

4800 North Scottsdale Road, Suite 2300, Scottsdale, AZ, 85251, United States

602-767-2100

lifestance.com

時価総額

$2.59B

PER (TTM)

265.3

52.6

配当利回り

52週高値

$8.09

52週安値

$3.74

52週レンジ

67%

順位63Top 94.0%

1.8

F-Score

改良版 Piotroski 分析

6年ファンダメンタル

弱い • 1.8 / 9 ポイント

スコアレンジ (0-9)

8-9: 価値が優れている

6-7: 基礎体質が強い

4-5: 全体的に堅調

0-3: パフォーマンスが弱い

データ期間: 2020-2025

財務ダッシュボード

Q4 2025 データ

売上高

$382.20M+0.00%

直近4四半期の推移

EPS

$0.03+0.00%

直近4四半期の推移

フリーCF

$82.77M+0.00%

直近4四半期の推移

2025 Annual 決算ハイライト

主なハイライト

Revenue Grows 14% Total revenue reached $1.424B USD, marking 14% growth driven by 1.1 million more patient visits.

Return to Net Income Profit Achieved $9.7M USD net income in 2025, reversing prior year's $57.4M USD net loss.

Platform Scale Expansion Platform scale expanded, treating over 1.0 million unique patients across 9.0 million visits in 2025.

Center Margin Improvement Center Margin increased to $461.1M USD, reflecting better control over direct patient care costs.

リスク要因

Payor Reimbursement Rate Risk Reduced reimbursement rates from payors, especially UnitedHealthcare (14%) and Elevance (15%), could harm financial condition.

Internal Control Material Weaknesses Material weaknesses exist in accounting policies and IT general controls; remediation efforts are ongoing as of year-end.

Clinician Labor Cost Pressure Recruiting and retaining 8,040 clinicians experienced increased labor costs, potentially reducing profitability going forward.

Regulatory Compliance Complexity Heavy federal and state regulation, including HIPAA and Stark Law, requires constant monitoring and compliance spending.

見通し

Drive Organic Capacity Growth Strategy focuses on growing clinician base via in-house recruiting model and opening new centers strategically.

Optimize Real Estate Footprint Prioritizing resources, company completed significant reduction in physical space following shift to more virtual visits.

Enhance Integrated Care Model Plan to deepen partnerships with primary care and specialty providers to drive integrated care delivery.

Manage Debt Obligations $282.8M USD debt outstanding requires cash flow management; refinancing terms remain uncertain for future needs.

同業比較

売上高 (TTM)

ARDT

$6.32B

+6.0%

SEM

$5.45B

+15.8%

ACHC

$3.31B

+5.0%

粗利益率 (最新四半期)

ARDT

165.5%

-25.6pp

ANIP

96.2%

-8.4pp

LMAT

71.7%

+7.5pp

主要指標

銘柄コード	時価総額	PER (TTM)	ROE (TTM)	負債比率
BKD	$3.45B	-12.9	-523.8%	112.0%
LFST	$2.59B	265.3	0.7%	8.8%
LMAT	$2.47B	42.6	15.6%	30.1%

長期トレンド

直近4四半期

売上高

純利益

営業キャッシュフロー

4四半期売上高CAGR

4.7%

緩やかな成長

4四半期純利益CAGR

154.4%

収益性の大幅な改善

キャッシュフロー安定性

75%

キャッシュフローの変動が大きい

深度リサーチ

次回決算:2026年5月6日

EPS:$0.01

売上高:$386.11M

財務データ

決算説明会

財務レポート

ニュース

損益計算書

バランスシート

キャッシュフロー計算書

財務比率

変化率

損益計算書	直近12ヶ月

データなし